中财网 中财网股票行情
泽璟制药-U(688266)财务分析指标    年份：
截止日期2024-03-312023-12-312023-09-302023-06-302023-03-31
营业总收入(万元)10824.4438643.8828210.4821992.8210811.05
营业收入(万元)10824.4438643.8828210.4821992.8210811.05
营业总成本(万元)15951.2078035.9954175.8736010.8917674.44
营业成本(万元)714.922921.212144.931648.94748.63
净利润(万元)-3941.94-28169.09-20068.60-11256.03-5785.75
归属于母公司的净利润(万元)-3949.94-27858.27-20208.94-11422.87-5722.76
营业利润(万元)-4562.43-29778.24-21636.76-12216.09-6036.68
利润总额(万元)-4562.38-29908.45-21726.77-12274.24-6083.92
少数股东损益(万元)-513.14-1655.22-1220.67-657.40-264.82
基本每股收益(元)-0.15(元)-1.09(元)-0.80(元)-0.46(元)-0.24(元)
稀释每股收益(元)-0.15(元)-1.09(元)-0.80(元)-0.46(元)-0.24(元)
非经常性损益(万元)300.357016.24--1578.09669.42
扣除非经常性损益后净利润(万元)-4250.29-34874.52-24328.07-13000.96-6392.19
总资产(万元)310474.80288720.68285906.19287096.11166496.01
总负债(万元)150403.60124236.98110962.77103037.9293057.02
归属于母公司股东权益合计(万元)159369.36163285.27173214.02181761.7270898.82
股东权益合计(万元)160071.20164483.70174943.42184058.1973438.99
实收资本(股本)(万元)26470.8226470.8226470.8226448.9824000.00
资本公积(万元)335326.63335300.60337128.86336865.83223001.62
未分配利润(万元)-201841.11-197891.17-190241.84-181455.77-175755.66
经营活动产生的现金流量净额(万元)8902.39-23275.06-22921.95-13371.61-3060.54
经营活动现金流入小计(万元)31002.4761187.0439778.6730020.1218143.87
经营活动现金流出小计(万元)22100.0984462.1162700.6243391.7421204.41
投资活动产生的现金流量净额(万元)-31590.156483.89-8245.08-42391.66-7449.54
投资活动现金流入小计(万元)11732.48126244.0166036.7330719.1415090.42
投资活动现金流出小计(万元)43322.63119760.1274281.8173110.8022539.96
筹资活动产生的现金流量净额(万元)9461.21150936.58147972.04138726.4410315.87
筹资活动现金流入小计(万元)34900.00217617.28193727.28159964.9926700.00
筹资活动现金流出小计(万元)25438.7966680.7045755.2421238.5516384.13
期末现金及现金等价物余额(万元)194552.25207777.72190446.87156615.3073395.80
最后修改日期2024-04-202024-04-202023-10-282023-08-272023-04-23
↑返回页顶↑

转至泽璟制药-U（688266）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。